Modi Ventures, a venture capital firm founded in 2022, specializes in companies at the intersection of artificial intelligence, biology, and medical technology. The firm recently announced the closing of its second fund, raising $88 million in an oversubscribed round.
Based in Houston’s TMC Helix Park at the Texas Medical Center, Modi Ventures launched its first fund in 2023, raising over $30 million. In just three months, it has secured funding for its second fund, designed to create resilient portfolios that can navigate market volatility.
Initial investments include Lila Sciences, RTW Royalty Fund, Ignota Labs, Latus Bio, and Flagship Pioneering.
KEY QUOTES:
“Modi Ventures invests strategically at the convergence of technology and biology, employing a sophisticated and proprietary financial engineering framework rooted in modern portfolio theory and the efficient frontier principles. The second fund will continue to help build companies at the intersection of AI, biology, and medicine, focusing on pioneering advancements in digital biology and multi-omics, cellular reprogramming, AI-driven drug discovery, next-generation diagnostics, and therapeutics.”
Sahir Ali, Modi Ventures’ solo general partner
“We’re proud to have witnessed the growth of Modi Ventures over the past few years at Helix Park, which is a cornerstone of Texas Medical Center’s vision to create a globally recognized hub for translational research and innovation. We look forward to continuing our partnership as we work together to build a world-class life sciences ecosystem right here in Houston.”
William McKeon, President and CEO of Texas Medical Center
